Xilio Therapeutics, Inc. PS Ratio 2021–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for Xilio Therapeutics, Inc. (XLO): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 1.14.

From: 06/30/2025To: 03/31/2026

Stock Price

TTM Revenue

PS Ratio

Xilio Therapeutics, Inc. PS Ratio — FAQ

Xilio Therapeutics, Inc. (XLO) ps ratio over the last 2 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see XLO's ps ratio history?

The chart and table above show Xilio Therapeutics, Inc.'s ps ratio by year and by quarter, including the growth rate.